Evidence map›Paper›PMID 41324448›Full record

ArticleThe ISME journal2025

Milk IgA promotes symbionts and limits pathobionts in the early life gut.

Katherine Donald, Antonio Serapio-Palacios, Tahereh Bozorgmehr, Mahebali Tabusi, B Brett Finlay

Abstract read
In one paragraph

Article in The ISME journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katherine DonaldDepartment of Microbiology & Immunology, University of British Columbia, 2350 Health Sciences Mall #1365, Vancouver, BC V6T 1Z3, Canada.
Antonio Serapio-PalaciosMichael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC V6T1Z4, Canada.
Tahereh BozorgmehrMichael Smith Laboratories, University of British Columbia, 2185 East Mall, Vancouver, BC V6T1Z4, Canada.
Mahebali TabusiDepartment of Microbiology & Immunology, University of British Columbia, 2350 Health Sciences Mall #1365, Vancouver, BC V6T 1Z3, Canada.
B Brett FinlayDepartment of Microbiology & Immunology, University of British Columbia, 2350 Health Sciences Mall #1365, Vancouver, BC V6T 1Z3, Canada.ORCID 0000-0001-5303-6128

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Secretory Immunoglobulin A (SIgA) is the dominant mucosal antibody and a key regulator of the gut microbiota. In early life, infants rely on breastmilk as their primary source of SIgA, but the role of milk-derived SIgA in early life microbiota colonization dynamics remains incompletely understood. Here, we show that species-specific SIgA in milk is antigen-inducible and discriminates between closely related but immunologically diverging microbes in the neonatal gut. More specifically, milk species-specific SIgA promotes colonization by an anti-inflammatory Escherichia coli strain while restricting the expansion of pro-inflammatory Proteus mirabilis. These findings uncover a dual role of maternal milk SIgA in actively sculpting the early life gut microbiota with species-level precision.

Indexed as

Gastrointestinal MicrobiomeImmunoglobulin A, SecretoryMilkMilk, HumanSymbiosisAnimalsEscherichia coliFemaleHumansMiceProteus mirabilisImmunoglobulin A, Secretorybreastmilk IgAearly-life microbiomehost–microbe interactionsmicrobiome development

Identifiers

PMID41324448
PMCPMC12704429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.